Pharmaceutical Packaging Market

Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled syringes), Drug Delivery, and Region - Global Forecast to 2027

Report Code: CH 3482 Nov, 2022, by marketsandmarkets.com

Updated on : March 20, 2023

Pharmaceutical Packaging Market Analysis

Pharmaceutical Packaging Market was valued at USD 99.9 billion in 2021 and is projected to reach USD 229.9 billion by 2027, growing at a cagr 14.9% from 2022 to 2027. The growing demand for pharmaceutical packaging is due to rising healthcare expenses, and growing consumer awareness regarding healthier lifestyle. Moreover, advanced drug delivery, growing emerging economy markets such as India, Thailand, China, and others, and innovative packaging solutions with higher patient convenience and compliance drive the market for pharmaceutical packaging.

Global Pharmaceutical Packaging Market Trends

Pharmaceutical Packaging Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact

Covid-19 pandemic had adverse effects on the healthcare industry. Shortage of infrastructure, manpower, disruptions in supply chain, lack of preparedness, shortage of essential drugs, and many other factors were responsible for the decline in healthcare industry functioning. The practices were not robust enough of handle such disruptions in supply chain, infrastructure, manpower and others. China, which was a major import destination of medical equipment’s, healthcare supply chain requirements, and drug formulations was reeling under the pandemic. This resulted in loss of stability in both the healthcare and pharmaceutical sectors. Global medical supply chain is still in a state of imbalance but is stabilizing as per the new normal. Pharmaceutical companies are also analyzing and updating their operation capabilities as per the current situation.

Durnig pandemic, packaging activies were considered essential. The pharmaceutical packaging companies have increased their production to keep up with the rising demand for blister packs, vials, prefilled syringes, containers, bottles and cartridges. This was mainly due to rise in the demand for Covid-related drugs and vaccines. In addition, pharmaceutical packaging for biologics, smart packaging, sterile packaging, patient focus packaging, cleanroom expansion, and others would propel the market in the long term.

Pharmaceutical packaging Market Dynamics

Driver: Technological advancements to contribute to growth of pharmaceutical packaging

Nano drug delivery systems are technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. These are new but rapidly developing technology for curing cancer, diabetes, cardiovascular, inflammatory, and microbial diseases. Nanotechnology offers many advantages in treating chronic diseases such as cardiovascular diseases (CVDs) by site-specific and target oriented delivery of drugs. CRP (Child-Resistant Packaging) is a special type of packaging used to reduce the risk of children handling and ingesting dangerous items. This packaging prevents children from opening a pharmaceutical product. CRP is required, by regulation, for prescription drugs, nicotine-based products, and over-the-counter medications. In developed countries, it is mandatory to use CRP for drugs such as aspirin, paracetamol, elemental iron, contraceptives, and others.

Restrain:Lack of access to proper healthcare

In developing economies, poverty is a significant obstacle to access healthcare facilities. The major challenges that limit the access of healthcare services are financial limitation, a lack of information, awareness of basic healthcare practices, and outdated equipment. These challenges limit the pharmaceutical packaging market in emerging nations like India, South Africa, Brazil and others. In India, a majority of the population is still suffering due to poor quality of healthcare and lack of access.

Opportunity: Growing demand for primary pharmaceutical packaging

Primary pharmaceutical packaging are products that come in direct contact with the medicine or drug. They generally include plastic bottles, glass bottles, pre-filled syringes, pre-filled inhalers, medication tubes, blister packaging, and others. The major contributors to the growth of this segment are pre-fillable syringes and pre-fillable inhalers. Plastic bottles, blister packs, and ampoules & vials are also some of the primary pharmaceutical packaging that are growing rapidly. Advancements in biotechnology, leading to the introduction of new injectable parenteral therapies, and increased demand for high visibility unit dosage packaging for diseases such as diabetes will drive the primary packaging segment.

Challenge: Safeguarding against counterfeit products

Counterfeit drugs are made with incorrect ingredients in inappropriate quantities, which when consumed would result in harmful effects such as allergic reactions or sometimes death. Nearly half of the counterfeit drugs are reported in developing economies such as China, the Philippines, and Vietnam. Delay in approval of new drugs and their packaging due to the long product development cycles and costs are resulting in the increased availability of counterfeit drugs and fake packaging. These counterfeit products have negative effects on the human body, in terms of allergic reactions, nausea, vomiting, and others. Safeguarding against these counterfeit products is a major challenge for the sector.

Plastics accounted for the largest share amongst other raw material in the pharmaceutical packaging market

Plastic offers design flexibility and cost-effective packaging solution, making it very suitable choice for pharmaceutical packaging. They are adopted for their enticing properties such as shatter resistance, rigidity, strength, light weighting, and moldability. Pharmaceutical packaging widely uses plastics as raw materials for. The excellent shatter resistance provided by plastics enables ease of handling and transportation. Plastic’s easy molding strength and efficiency as barrier against vapour and gas are further benefits.

Plastic bottles accounted for the largest market share amongst other types in the pharmaceutical packaging market

Pharmaceutical most common type of packaging item is Plastic bottles. They are suitable for storage of drugs in liquid and solid forms. Plastic bottles can be coupled with the appropriate type of cap & closure to suit specific applications such as nasal spray and ophthalmic drops. Plastic bottles are used in various types of packaging such as rigid form for solid dosages, sterile packaging for blood and related components, squeezable bottles, jars, and others. Growing patient compliance and convenience with oral drug delivery, increasing cases of communicable diseases, and rise in aging population in developed economies are responsible for the high share of the bottles segment.

Nasal is projected to be the second highest CAGR in pharmaceutical packaging drug delivery mode during forecast period.

Nasal drugs used are generally in liquid formulation, but powder form can also offer higher stability and support new device developments in the future. Nasal drug delivery containers are also known as nasal sprays. These drug products have therapeutically active ingredients dissolved or suspended in solutions or mixtures of excipients in non-pressurized dispensers to deliver a spray containing a metered dose of the active ingredient. The dose can be metered by the spray pump or be pre-metered during manufacture.

Asia Pacific is projected to grow the fastest in the pharmaceutical packaging market during the forecast period.

Asia Pacific is predicted to be the fastest-growing region amongst others in the pharmaceutical packaging market in 2020. Increasing government initiatives in emerging pharmaceutical market, increase in contract manufacturing activities, rise in aging population, and increased spending on healthcare are driving the market in Asia Pacific. China, Australia, Japan, South Korea, and India are the major markets in this region. India and China are investing heavily in their respective healthcare sectors, which is going to benefit the rapidly growing pharmaceuticals industry. In addition, growing technological advancements in healthcare sector in countries such as Singapore, China, Malaysia, Thailand, and others, increasing urbanization, and changing lifestyle are also some of the driving factors for the market growth in pharmaceutical packaging industry.

Pharmaceutical Packaging Market by Region

Source: Secondary Research, Primary Interviews, and MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The key players in the pharmaceutical packaging market include Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US). The pharmaceutical packaging market report analyzes the key growth strategies, such as new product launches, investments & expansions, joint ventures, agreements, partnerships, and mergers & acquisitions adopted by the leading market players between 2019 and 2022.

Pharmaceutical Packaging Market Report Scope

Report Metric

Details

Market Size Value in 2021

USD 99.9 Billion

Revenue Forecast in 2027

USD 229.9 Billion

CAGR

14.9%

Years considered for the study

2020–2027

Base year considered

2021

Forecast period

2022–2027

Units considered

Volume (Kiloton) and Value (USD)

Segments

Raw Material, Types, Drug Delivery Modes, and Region

Regions

North America, Asia Pacific, Europe, Middle East & Africa, and South America

Companies

Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US)
25 major players covered.

This research report categorizes the pharmaceutical packaging market based on raw material, types, drug delivery modes, and region.

By Material:
  • Plastics
  • Paper & paperboard
  • Glass
  • Metal
  • Others
By Drug Delivery
  • Oral Drugs
  • Injectables
  • Topical
  • Ocular/ Ophthalmic
  • Nasal
  • Pulmonary
  • Transdermal
  • IV Drugs
  • Others
By Type
  • Plastic bottles
  • Blister
  • Labels & accessories
  • Caps & closures
  • Pre-filled syringes
  • Medical specialty bags
  • Temp controlled packaging
  • Pouches & strip packs
  • Pre-filled inhalers
  • Vials
  • Ampoules
  • Medication tubes
  • Jars & Canisters
  • Cartridges
  • Others
By Region
  • North America
  • Aisa Pacific
  • Europe
  • Middle East & Africa
  • South America

The pharmaceutical packaging market has been further analyzed based on key countries in each of these regions.

Recent Developments

  • In January 2022, Berry Global Group and Raw Elements USA Collaborated to launch sustainable tube made from sugarcane. The tubes are made from sugarcane waste that is converted into HDPE and LDPE to create a material with the same chemical makeup of fossil fuel-based polyethylene.
  • In July 2022, Gerresheimer AG and Stevanato Group announce collaboration, to develop a new ready-to-use solution platform based on EZ-fill® pre-sterilized platform.
  • In June 2021, Amcor PLC introduced ACT2100 heat seal coating for medical grade DuPont Tyvek2 and paper packaging applications. This next generation coating technology delivers enhanced performance features for healthcare applications.
  • In August 2021, Schott AG and Serum Institute of India Announce Joint Venture for Pharmaceutical Packaging. Serum Institute of India (SII) acquires 50% stake of Schott Kaisha to become Schott’s joint venture partner and secure pharma packaging supply.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 38)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 STUDY SCOPE 
          FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
           1.3.1 REGIONS COVERED
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 UNIT CONSIDERED 
    1.6 STAKEHOLDERS 
    1.7 INCLUSIONS & EXCLUSIONS 
          TABLE 1 PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS & EXCLUSIONS
    1.8 SUMMARY OF CHANGES 
    1.9 LIMITATIONS 
 
2 RESEARCH METHODOLOGY (Page No. - 43)
    2.1 IMPACT OF RECESSION 
    2.2 RESEARCH DATA 
          FIGURE 2 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
           2.2.1 SECONDARY DATA
                    2.2.1.1 Major secondary sources
                    2.2.1.2 Key data from secondary sources
           2.2.2 PRIMARY DATA
           2.2.3 PRIMARY INTERVIEWS
                    2.2.3.1 Demand and supply sides
                    2.2.3.2 Key data from primary sources
                    2.2.3.3 Key industry insights
                    2.2.3.4 Breakdown of primary interviews
    2.3 MARKET SIZE ESTIMATION 
           2.3.1 BOTTOM-UP APPROACH
                    FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH
           2.3.2 TOP-DOWN APPROACH
                    FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH
    2.4 DATA TRIANGULATION 
          FIGURE 5 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
           2.4.1 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH PRIMARY INTERVIEWS
           2.4.2 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH SECONDARY SOURCES
                    FIGURE 6 PHARMACEUTICAL PACKAGING MARKET ANALYSIS
    2.5 RESEARCH LIMITATIONS 
    2.6 RESEARCH ASSUMPTIONS 
    2.7 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 
           2.7.1 SUPPLY SIDE
           2.7.2 DEMAND SIDE
           2.7.3 INSIGHTS FROM KEY RESPONDENTS
    2.8 RISK ASSESSMENT 
 
3 EXECUTIVE SUMMARY (Page No. - 56)
    FIGURE 7 PLASTIC BOTTLES TO BE LARGEST TYPE OF PHARMACEUTICAL PACKAGING
    FIGURE 8 PLASTICS TO BE LARGEST RAW MATERIAL FOR PHARMACEUTICAL PACKAGING
    FIGURE 9 ORAL DRUG DELIVERY MODE TO BE LARGEST SEGMENT OF PHARMACEUTICAL PACKAGING MARKET
    FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET
 
4 PREMIUM INSIGHTS (Page No. - 60)
    4.1 EMERGING ECONOMIES TO WITNESS HIGH GROWTH DURING FORECAST PERIOD 
          FIGURE 11 ASIA PACIFIC TO OFFER ATTRACTIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET
    4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE 
          FIGURE 12 PLASTIC BOTTLES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
    4.3 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 
          FIGURE 13 PLASTICS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
    4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE 
          FIGURE 14 ORAL DRUG DELIVERY MODE TO LEAD MARKET BY 2027
    4.5 GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY 
          FIGURE 15 MARKET IN INDIA TO GROW AT HIGHEST CAGR
 
5 MARKET OVERVIEW (Page No. - 63)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET
           5.2.1 DRIVERS
                    5.2.1.1 Growing healthcare expenditure and pharmaceutical industry in emerging economies
                    5.2.1.2 Rising demand for drug delivery devices and blister packaging
                    5.2.1.3 Technological advancements
                               5.2.1.3.1 Nanomedicine and nano drug delivery systems (NDDS)
                               5.2.1.3.2 Child-resistant packaging (CRP)
                               5.2.1.3.3 Radio-frequency identification (RFID)
                               5.2.1.3.4 Micropump technology
                               5.2.1.3.5 Eco-friendly and sustainable packaging
           5.2.2 RESTRAINTS
                    5.2.2.1 Increasing overall packaging costs due to dynamic regulatory policies
                    5.2.2.2 Lack of access to proper healthcare in emerging economies
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing demand for primary pharmaceutical packaging
           5.2.4 CHALLENGES
                    5.2.4.1 Safeguarding against counterfeit products
    5.3 VALUE CHAIN ANALYSIS 
          FIGURE 17 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS
           5.3.1 RAW MATERIAL SUPPLIERS
           5.3.2 R&D OF PRODUCTS
           5.3.3 MANUFACTURERS
           5.3.4 DISTRIBUTORS
           5.3.5 END USERS
                    TABLE 2 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN STAKEHOLDERS
    5.4 PORTER'S FIVE FORCES ANALYSIS 
          FIGURE 18 PORTER'S FIVE FORCES ANALYSIS: PHARMACEUTICAL PACKAGING MARKET
           5.4.1 THREAT OF NEW ENTRANTS
           5.4.2 THREAT OF SUBSTITUTES
           5.4.3 BARGAINING POWER OF BUYERS
           5.4.4 BARGAINING POWER OF SUPPLIERS
           5.4.5 INTENSITY OF COMPETITIVE RIVALRY
                    TABLE 3 IMPACT OF PORTER'S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET
    5.5 MACROECONOMIC INDICATORS 
           5.5.1 GLOBAL GDP TRENDS
                    TABLE 4 TRENDS OF PER CAPITA GDP (USD) 2019–2021
                    TABLE 5 GDP GROWTH ESTIMATE AND PROJECTION OF KEY COUNTRIES, 2022–2027
                    TABLE 6 CURRENT HEALTH EXPENDITURE (% OF GDP) OF KEY COUNTRIES, 2018–2019
    5.6 REGULATORY LANDSCAPE 
           5.6.1 REGULATIONS
                    5.6.1.1 Europe
                    5.6.1.2 US
                    5.6.1.3 Others
    5.7 TECHNOLOGY ANALYSIS 
           5.7.1 NANOTECHNOLOGY
           5.7.2 PACKAGING FOR BIOLOGICS
           5.7.3 SMART PACKAGING
           5.7.4 ANTI-COUNTERFEIT PACKAGING
           5.7.5 OTHER SMART TRENDS AND TECHNOLOGIES
    5.8 PRICING ANALYSIS 
           5.8.1 AVERAGE SELLING PRICE, BY REGION
                    FIGURE 19 AVERAGE SELLING PRICE, BY REGION (USD/KG)
           5.8.2 AVERAGE SELLING PRICE, BY RAW MATERIAL
                    TABLE 7 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG)
           5.8.3 AVERAGE SELLING PRICE, BY COMPANY
                    TABLE 8 AVERAGE SELLING PRICE, BY COMPANY (USD/KG)
    5.9 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING 
           FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING
    5.1 IMPACT OF COVID-19 ON PHARMACEUTICAL PACKAGING MARKET 
           5.10.1 IMPACT ON HEALTHCARE INDUSTRY
    5.11 IMPACT OF RECESSION ON PHARMACEUTICAL PACKAGING MARKET 
    5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 
           FIGURE 21 SUSTAINABLE PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE GROWTH
    5.13 PATENT ANALYSIS 
           5.13.1 INTRODUCTION
           5.13.2 METHODOLOGY
           5.13.3 DOCUMENT TYPE
                     FIGURE 22 PATENTS REGISTERED (2011–2021)
           5.13.4 PUBLICATION TRENDS – LAST 10 YEARS
                     FIGURE 23 NUMBER OF PATENTS IN LAST 10 YEARS, 2011–2021
           5.13.5 INSIGHTS
           5.13.6 JURISDICTION ANALYSIS
                     FIGURE 24 TOP JURISDICTIONS
           5.13.7 TOP PATENT APPLICANTS
                     FIGURE 25 TOP 10 PATENT APPLICANTS
                     TABLE 9 LIST OF PATENTS BY SANOFI AVENTIS DEUTSCHLAND
                     TABLE 10 LIST OF PATENTS BY SCHOTT AG
                     TABLE 11 LIST OF PATENTS BY TERUMO CORP
                     TABLE 12 LIST OF PATENTS BY BECTON DICKINSON AND COMPANY
                     TABLE 13 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS
    5.14 RAW MATERIAL ANALYSIS 
           5.14.1 PLASTICS
           5.14.2 PAPER
           5.14.3 GLASS
           5.14.4 METALS
    5.15 TRADE ANALYSIS 
    5.16 OPERATIONAL DATA 
    5.17 KEY CONFERENCES AND EVENTS (2022–2023) 
          TABLE 14 KEY CONFERENCES AND EVENTS (2022–2023)
    5.18 CASE STUDY ANALYSIS 
           5.18.1 MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY
           5.18.2 CUSTOM TECHNOLOGY FOR BETTER BREATHING
 
6 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL (Page No. - 96)
    6.1 INTRODUCTION 
          FIGURE 26 PLASTICS SEGMENT TO DOMINATE PHARMACEUTICAL PACKAGING MARKET
          TABLE 15 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING
          TABLE 16 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
          TABLE 17 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
          TABLE 18 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
          TABLE 19 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
          TABLE 20 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
          TABLE 21 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
          TABLE 22 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
          TABLE 23 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
    6.2 PLASTICS 
           6.2.1 EXCELLENT SHATTER RESISTANCE OF PLASTICS TO BOOST ITS USE IN PRIMARY PACKAGING
                    TABLE 24 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 25 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 26 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
                    TABLE 27 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
           6.2.2 HIGH-DENSITY POLYETHYLENE (HDPE)
           6.2.3 POLYESTER
           6.2.4 POLYPROPYLENE (PP)
           6.2.5 LOW-DENSITY POLYETHYLENE (LDPE)
           6.2.6 POLYVINYL CHLORIDE (PVC)
           6.2.7 CYCLIC OLEFIN COPOLYMER (COC)
           6.2.8 POLYETHYLENE TEREPHTHALATE (PET)
    6.3 PAPER & PAPERBOARD 
           6.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL USE OF PAPER & PAPERBOARD
                    TABLE 28 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 29 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 30 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
                    TABLE 31 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
    6.4 GLASS 
           6.4.1 EXCELLENT CHEMICAL RESISTANCE OF GLASS TO BOOST ITS USE IN PRIMARY PACKAGING
                    TABLE 32 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 33 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 34 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
                    TABLE 35 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
                    TABLE 36 TYPES OF GLASS USED FOR DIFFERENT PACKAGING
    6.5 METALS 
           6.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO BOOST MARKET
                    TABLE 37 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 38 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
                    TABLE 39 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
                    TABLE 40 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
    6.6 OTHERS 
          TABLE 41 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
          TABLE 42 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
          TABLE 43 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON)
          TABLE 44 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON)
 
7 PHARMACEUTICAL PACKAGING MARKET, BY TYPE (Page No. - 114)
    7.1 INTRODUCTION 
          FIGURE 27 PLASTIC BOTTLES ACCOUNTED FOR LARGEST SHARE OF PHARMACEUTICAL PACKAGING MARKET
          TABLE 45 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
          TABLE 46 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
          TABLE 47 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION)
          TABLE 48 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION)
    7.2 PLASTIC BOTTLES 
           7.2.1 EASY OPERABILITY, SHATTER RESISTANCE, AND LIGHTWEIGHT PROPERTIES TO DRIVE DEMAND
                    TABLE 49 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 50 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
           7.2.2 STANDARD PLASTIC BOTTLES
           7.2.3 PLASTIC DISPENSING BOTTLES
           7.2.4 PLASTIC JARS
    7.3 BLISTER PACKS 
           7.3.1 EFFECTIVE DRUG PROTECTION AND EASY MANUFACTURING TO DRIVE MARKET
                    TABLE 51 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 52 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
           7.3.2 COMPARTMENT PACKS
           7.3.3 WALLET PACKS
    7.4 LABELS & ACCESSORIES 
           7.4.1 PATIENT-DRUG COMMUNICATION COMPLIANCE TO BOOST DEMAND
                    TABLE 53 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 54 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
           7.4.2 SELF-ADHESIVE LABELS
           7.4.3 DIE-CUT LABELS
           7.4.4 TAMPER-PROOF LABELS
           7.4.5 HOLOGRAPHIC STRIP LABELS
    7.5 CAPS & CLOSURES 
           7.5.1 DEMAND FOR TAMPER-EVIDENT PACKAGING TO PROPEL MARKET
                    TABLE 55 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 56 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    7.6 MEDICAL SPECIALTY BAGS 
           7.6.1 EASY HANDLING AND DISPOSABLE CHARACTERISTICS TO FUEL DEMAND
                    TABLE 57 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 58 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    7.7 PREFILLED SYRINGES 
           7.7.1 SELF-MEDICATION AND INCREASING CHRONIC DISEASES TO DRIVE DEMAND
                    TABLE 59 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 60 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    7.8 TEMPERATURE-CONTROLLED PACKAGING 
           7.8.1 INCREASING MANUFACTURING OF SPECIALIZED DRUGS TO FUEL MARKET
                    TABLE 61 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 62 TEMPERATURE CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    7.9 POUCHES & STRIP PACKS 
           7.9.1 INCREASING DEMAND FOR STANDUP POUCHES TO OFFER GROWTH OPPORTUNITIES
                    TABLE 63 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 64 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    7.10 AMPOULES 
           7.10.1 INCREASING DEMAND FROM DEVELOPING COUNTRIES TO DRIVE MARKET
                    TABLE 65 AMPOULES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 66 AMPOULES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    7.11 VIALS 
           7.11.1 DEMAND FOR VIALS IN VACCINE PACKAGING TO SUPPORT MARKET GROWTH
                    TABLE 67 VIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 68 VIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    7.12 PREFILLED INHALERS 
           7.12.1 INCREASING CASES OF PULMONARY DISEASES TO DRIVE DEMAND
                    TABLE 69 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 70 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
           7.12.2 METERED DOSE INHALERS
           7.12.3 DRY POWDER INHALERS
    7.13 MEDICATION TUBES 
           7.13.1 EASE OF USE TO INCREASE DEMAND
                    TABLE 71 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 72 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
           7.13.2 COMPOSITE TUBES
           7.13.3 ALL-PLASTIC TUBES
           7.13.4 COLLAPSIBLE METAL TUBES
    7.14 JARS & CANISTERS 
           7.14.1 EFFECTIVE BARRIER PROPERTIES TO PROPEL DEMAND
                    TABLE 73 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 74 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    7.15 CARTRIDGES 
           7.15.1 COMPATIBILITY WITH A VARIETY OF DEVICES TO DRIVE MARKET
                    TABLE 75 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 76 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    7.16 OTHERS 
          TABLE 77 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
          TABLE 78 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
 
8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE (Page No. - 136)
    8.1 INTRODUCTION 
          FIGURE 28 ORAL DRUG DELIVERY MODE TO BE LARGEST SEGMENT IN 2022
          TABLE 79 DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
          TABLE 80 DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
          TABLE 81 PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2018–2021 (USD MILLION)
          TABLE 82 PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2022–2027 (USD MILLION)
    8.2 ORAL DRUG DELIVERY MODE 
           8.2.1 HIGH DEMAND FOR ORAL DRUG DELIVERY MODE OWING TO EASE OF USE
                    TABLE 83 ORAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 84 ORAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    8.3 INJECTABLE DRUG DELIVERY MODE 
           8.3.1 HIGH BIOAVAILABILITY AND EFFICIENT TREATMENT TO BOOST THIS SEGMENT
                    TABLE 85 INJECTABLE DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 86 INJECTABLE DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    8.4 TOPICAL DRUG DELIVERY MODE 
           8.4.1 PREVALENCE OF SKIN DISEASES TO DRIVE MARKET FOR TOPICAL FORMULATIONS
                    TABLE 87 TOPICAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 88 TOPICAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    8.5 OCULAR/OPHTHALMIC DRUG DELIVERY MODE 
           8.5.1 INCREASING PREVALENCE OF EYE DISORDERS AND AGING POPULATION TO FUEL CONSUMPTION
                    TABLE 89 OCULAR/OPHTHALMIC DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 90 OCULAR/OPHTHALMIC DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    8.6 NASAL DRUG DELIVERY MODE 
           8.6.1 RAPID ABSORPTION AND FASTER ONSET OF ACTION TO PROPEL MARKET
                    TABLE 91 NASAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 92 NASAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    8.7 PULMONARY DRUG DELIVERY MODE 
           8.7.1 INCREASING CASES OF LUNG-RELATED DISEASES TO BOOST DEMAND
                    TABLE 93 PULMONARY DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 94 PULMONARY DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    8.8 TRANSDERMAL DRUG DELIVERY MODE 
           8.8.1 INCREASING SMALL-DOSE DRUG USE TO FUEL MARKET
                    TABLE 95 TRANSDERMAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 96 TRANSDERMAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    8.9 IV DRUG DELIVERY MODE 
           8.9.1 IMPROVED PATIENT COMPLIANCE AND HIGH DRUG DOSE CAPABILITY TO DRIVE DEMAND
                    TABLE 97 IV DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
                    TABLE 98 IV DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    8.10 OTHER DRUG DELIVERY MODES 
           TABLE 99 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
           TABLE 100 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
 
9 PHARMACEUTICAL PACKAGING MARKET, BY REGION (Page No. - 150)
    9.1 INTRODUCTION 
          FIGURE 29 PHARMACEUTICAL PACKAGING MARKET IN INDIA TO REGISTER HIGHEST CAGR
          TABLE 101 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION)
          TABLE 102 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
    9.2 NORTH AMERICA 
           9.2.1 RECESSION IMPACT
                    FIGURE 30 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
                    TABLE 103 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 104 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
                    TABLE 105 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                    TABLE 106 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
                    TABLE 107 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION)
                    TABLE 108 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION)
                    TABLE 109 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION)
                    TABLE 110 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION)
                    TABLE 111 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
                    TABLE 112 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
                    TABLE 113 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
                    TABLE 114 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
           9.2.2 US
                    9.2.2.1 Rapid technological advancements
                                TABLE 115 US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 116 US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.2.3 CANADA
                    9.2.3.1 Competitive business environment to boost market
                                TABLE 117 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 118 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.2.4 MEXICO
                    9.2.4.1 Government initiatives in healthcare industry to fuel demand
                                TABLE 119 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 120 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
    9.3 EUROPE 
           9.3.1 RECESSION IMPACT
                    TABLE 121 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 122 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
                    TABLE 123 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                    TABLE 124 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
                    TABLE 125 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION)
                    TABLE 126 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION)
                    TABLE 127 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION)
                    TABLE 128 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION)
                    TABLE 129 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
                    TABLE 130 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
                    TABLE 131 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
                    TABLE 132 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
           9.3.2 GERMANY
                    9.3.2.1 Increase in aging population and non-communicable diseases to drive market
                                TABLE 133 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 134 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 High demand for generic drugs to drive market
                                TABLE 135 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 136 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Growing exports of pharmaceuticals to impact market growth
                                TABLE 137 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 138 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.3.5 UK
                    9.3.5.1 Innovation in drug manufacturing to increase demand
                                TABLE 139 UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 140 UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.3.6 SPAIN
                    9.3.6.1 Government initiatives in healthcare sector to boost demand
                                TABLE 141 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 142 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.3.7 RUSSIA
                    9.3.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market
                                TABLE 143 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 144 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.3.8 REST OF EUROPE
                    TABLE 145 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                    TABLE 146 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
    9.4 ASIA PACIFIC 
           9.4.1 RECESSION IMPACT
                    FIGURE 31 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
                    TABLE 147 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 148 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
                    TABLE 149 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                    TABLE 150 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
                    TABLE 151 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION)
                    TABLE 152 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION)
                    TABLE 153 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION)
                    TABLE 154 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION)
                    TABLE 155 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
                    TABLE 156 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
                    TABLE 157 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
                    TABLE 158 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
           9.4.2 CHINA
                    9.4.2.1 Increased investments in R&D of biologics and biosimilar drugs to drive market
                                TABLE 159 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 160 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.4.3 JAPAN
                    9.4.3.1 Sizeable aging population to drive demand for medications
                                TABLE 161 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 162 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.4.4 SOUTH KOREA
                    9.4.4.1 Well-developed healthcare industry and presence of major pharmaceuticals manufacturers to drive market
                                TABLE 163 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 164 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.4.5 INDIA
                    9.4.5.1 Large domestic consumption and export of generic drugs to drive market
                                TABLE 165 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 166 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.4.6 AUSTRALIA
                    9.4.6.1 Medicare and PBS schemes strengthening country’s pharmaceutical industry to drive market
                                TABLE 167 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 168 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.4.7 REST OF ASIA PACIFIC
                    TABLE 169 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                    TABLE 170 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
    9.5 SOUTH AMERICA 
           9.5.1 RECESSION IMPACT
                    TABLE 171 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 172 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
                    TABLE 173 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                    TABLE 174 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
                    TABLE 175 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION)
                    TABLE 176 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION)
                    TABLE 177 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION)
                    TABLE 178 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION)
                    TABLE 179 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
                    TABLE 180 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
                    TABLE 181 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
                    TABLE 182 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
           9.5.2 BRAZIL
                    9.5.2.1 Free and universal healthcare services to support growth of pharmaceutical industry
                                TABLE 183 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 184 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.5.3 ARGENTINA
                    9.5.3.1 Plastic bottles to account for largest market share
                                TABLE 185 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 186 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.5.4 REST OF SOUTH AMERICA
                    TABLE 187 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                    TABLE 188 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 RECESSION IMPACT
                    TABLE 189 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION)
                    TABLE 190 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
                    TABLE 191 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                    TABLE 192 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
                    TABLE 193 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION)
                    TABLE 194 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION)
                    TABLE 195 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION)
                    TABLE 196 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION)
                    TABLE 197 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION)
                    TABLE 198 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION)
                    TABLE 199 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON)
                    TABLE 200 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON)
           9.6.2 SAUDI ARABIA
                    9.6.2.1 Wider access to healthcare services to increase demand for pharmaceuticals
                                TABLE 201 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 202 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.6.3 SOUTH AFRICA
                    9.6.3.1 Gradual rise in generic drug use to fuel pharmaceutical packaging market
                                TABLE 203 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 204 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.6.4 UAE
                    9.6.4.1 Increasing initiatives for domestic pharmaceutical production to drive market
                                TABLE 205 UAE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                                TABLE 206 UAE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
           9.6.5 REST OF MIDDLE EAST & AFRICA
                    TABLE 207 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION)
                    TABLE 208 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 231)
     10.1 OVERVIEW 
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 32 COMPANIES ADOPTED INVESTMENT & EXPANSION AND NEW PRODUCT DEVELOPMENT AS KEY GROWTH STRATEGIES
     10.3 MARKET EVALUATION MATRIX 
             TABLE 209 MARKET EVALUATION MATRIX
     10.4 REVENUE ANALYSIS 
             TABLE 210 REVENUE OF KEY COMPANIES IN LAST THREE YEARS
     10.5 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2021 
             FIGURE 33 RANKING OF TOP 5 PLAYERS IN PHARMACEUTICAL PACKAGING MARKET, 2021
             10.5.1 BERRY GLOBAL INC.
             10.5.2 AMCOR PLC
             10.5.3 APTARGROUP, INC.
             10.5.4 GERRESHEIMER AG
             10.5.5 SCHOTT AG
     10.6 MARKET SHARE ANALYSIS 
             FIGURE 34 PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2021)
             TABLE 211 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION
     10.7 COMPANY EVALUATION MATRIX (TIER 1) 
             10.7.1 STARS
             10.7.2 PERVASIVE PLAYERS
             10.7.3 EMERGING LEADERS
             10.7.4 PARTICIPANTS
                        FIGURE 35 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR TIER 1 COMPANIES, 2021
     10.8 STRENGTH OF PRODUCT PORTFOLIO 
     10.9 BUSINESS STRATEGY EXCELLENCE 
     10.1 COMPANY EVALUATION MATRIX (START-UPS AND SMES) 
             10.10.1 PROGRESSIVE COMPANIES
             10.10.2 RESPONSIVE COMPANIES
             10.10.3 STARTING BLOCKS
             10.10.4 DYNAMIC COMPANIES
                        FIGURE 36 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS AND SMES, 2021
     10.11 STRENGTH OF PRODUCT PORTFOLIO (START-UPS AND SMES) 
     10.12 BUSINESS STRATEGY EXCELLENCE (START-UPS AND SMES) 
     10.13 COMPETITIVE BENCHMARKING 
              TABLE 212 PHARMACEUTICAL PACKAGING MARKET: DETAILED LIST OF COMPANIES
             10.13.1 COMPANY DRUG DELIVERY MODE FOOTPRINT
                          TABLE 213 OVERALL DRUG DELIVERY MODE FOOTPRINT
             10.13.2 COMPANY TYPE FOOTPRINT
                          TABLE 214 OVERALL TYPE FOOTPRINT
             10.13.3 COMPANY REGION FOOTPRINT
                          TABLE 215 OVERALL REGION FOOTPRINT
             10.13.4 COMPANY FOOTPRINT
                          TABLE 216 OVERALL COMPANY FOOTPRINT
     10.14 COMPETITIVE SITUATION AND TRENDS 
             10.14.1 PRODUCT LAUNCHES
                          TABLE 217 PHARMACEUTICAL PACKAGING: PRODUCT LAUNCHES, 2018–NOVEMBER 2022
             10.14.2 DEALS
                          TABLE 218 PHARMACEUTICAL PACKAGING: DEALS, 2018–NOVEMBER 2022
             10.14.3 OTHERS
                          TABLE 219 PHARMACEUTICAL PACKAGING MARKET: OTHERS, 2018–NOVEMBER 2022
 
11 COMPANY PROFILES (Page No. - 262)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
     11.1 BERRY GLOBAL INC. 
             TABLE 220 BERRY GLOBAL: COMPANY OVERVIEW
             FIGURE 37 BERRY GLOBAL: COMPANY SNAPSHOT
             TABLE 221 BERRY GLOBAL: PRODUCTS OFFERED
             TABLE 222 BERRY GLOBAL: PRODUCT LAUNCHES
             TABLE 223 BERRY GLOBAL: DEALS
             TABLE 224 BERRY GLOBAL: OTHER DEVELOPMENTS
     11.2 GERRESHEIMER AG 
             TABLE 225 GERRESHEIMER AG: COMPANY OVERVIEW
             FIGURE 38 GERRESHEIMER AG: COMPANY SNAPSHOT
             TABLE 226 GERRESHEIMER AG: PRODUCTS OFFERED
             TABLE 227 GERRESHEIMER AG: PRODUCT LAUNCHES
             TABLE 228 GERRESHEIMER AG: OTHER DEVELOPMENTS
     11.3 AMCOR PLC 
             TABLE 229 AMCOR PLC: COMPANY OVERVIEW
             FIGURE 39 AMCOR: COMPANY SNAPSHOT
             TABLE 230 AMCOR: PRODUCTS OFFERED
             TABLE 231 AMCOR: PRODUCT LAUNCHES
             TABLE 232 AMCOR: DEALS
             TABLE 233 AMCOR: OTHER DEVELOPMENTS
     11.4 SCHOTT AG 
             TABLE 234 SCHOTT AG: COMPANY OVERVIEW
             FIGURE 40 SCHOTT AG: COMPANY SNAPSHOT
             TABLE 235 SCHOTT AG: PRODUCTS OFFERED
             TABLE 236 SCHOTT AG: PRODUCT LAUNCHES
             TABLE 237 SCHOTT AG: DEALS
             TABLE 238 SCHOTT AG: OTHER DEVELOPMENTS
     11.5 APTARGROUP, INC. 
             TABLE 239 APTARGROUP, INC.: COMPANY OVERVIEW
             FIGURE 41 APTARGROUP: COMPANY SNAPSHOT
             TABLE 240 APTARGROUP: PRODUCTS OFFERED
             TABLE 241 APTARGROUP: PRODUCT LAUNCHES
             TABLE 242 APTARGROUP: DEALS
             TABLE 243 APTARGROUP: OTHER DEVELOPMENTS
     11.6 BECTON, DICKINSON AND COMPANY 
             TABLE 244 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
             FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
             TABLE 245 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
             TABLE 246 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES
             TABLE 247 BECTON, DICKINSON AND COMPANY: DEALS
             TABLE 248 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS
     11.7 WESTROCK COMPANY 
             TABLE 249 WESTROCK COMPANY: COMPANY OVERVIEW
             FIGURE 43 WESTROCK COMPANY: COMPANY SNAPSHOT
             TABLE 250 WESTROCK COMPANY: PRODUCTS OFFERED
             TABLE 251 WESTROCK COMPANY: OTHER DEVELOPMENTS
     11.8 NIPRO CORPORATION 
             TABLE 252 NIPRO CORPORATION: COMPANY OVERVIEW
             FIGURE 44 NIPRO CORPORATION: COMPANY SNAPSHOT
             TABLE 253 NIPRO CORPORATION: PRODUCTS OFFERED
             TABLE 254 NIPRO CORPORATION: DEALS
     11.9 CATALENT, INC. 
             TABLE 255 CATALENT, INC.: COMPANY OVERVIEW
             FIGURE 45 CATALENT: COMPANY SNAPSHOT
             TABLE 256 CATALENT: PRODUCTS OFFERED
             TABLE 257 CATALENT: DEALS
             TABLE 258 CATALENT: OTHER DEVELOPMENTS
     11.10 SEALED AIR 
             TABLE 259 SEALED AIR: COMPANY OVERVIEW
             FIGURE 46 SEALED AIR: COMPANY SNAPSHOT
             TABLE 260 SEALED AIR: PRODUCTS OFFERED
             TABLE 261 SEALED AIR: PRODUCT LAUNCHES
             TABLE 262 SEALED AIR: DEALS
     11.11 WEST PHARMACEUTICAL SERVICES, INC. 
             TABLE 263 WEST PHARMACEUTICAL SERVICES: COMPANY OVERVIEW
             FIGURE 47 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
             TABLE 264 WEST PHARMACEUTICAL SERVICES: PRODUCTS OFFERED
             TABLE 265 WEST PHARMACEUTICAL SERVICES: PRODUCT LAUNCHES
             TABLE 266 WEST PHARMACEUTICAL SERVICES: OTHER DEVELOPMENTS
     11.12 OTHERS 
             11.12.1 ALPLA WERKE ALWIN LEHNER GMBH & CO KG
                          TABLE 267 ALPLA WERKE ALWIN LEHNER GMBH & CO KG: COMPANY OVERVIEW
             11.12.2 ARDAGH GROUP S.A.
                          TABLE 268 ARDAGH GROUP S.A.: COMPANY OVERVIEW
             11.12.3 CCL INDUSTRIES INC.
                          TABLE 269 CCL INDUSTRIES INC.: COMPANY OVERVIEW
             11.12.4 FRANK NOE EGYPT LTD.
                          TABLE 270 FRANK NOE EGYPT LTD.: COMPANY OVERVIEW
             11.12.5 GAPLAST GMBH
                          TABLE 271 GAPLAST GMBH: COMPANY OVERVIEW
             11.12.6 LONZA GROUP LTD.
                          TABLE 272 LONZA GROUP LTD.: COMPANY OVERVIEW
             11.12.7 MONDI GROUP
                          TABLE 273 MONDI GROUP: COMPANY OVERVIEW
             11.12.8 NOLATO AB
                          TABLE 274 NOLATO AB: COMPANY OVERVIEW
             11.12.9 ORIGIN PHARMA PACKAGING
                          TABLE 275 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW
             11.12.10 COMAR
                          TABLE 276 COMAR: COMPANY OVERVIEW
             11.12.11 BILCARE LIMITED
                          TABLE 277 BILCARE LIMITED: COMPANY OVERVIEW
             11.12.12 SGD PHARMA
                          TABLE 278 SGD PHARMA: COMPANY OVERVIEW
             11.12.13 SILGAN HOLDINGS INC.
                          TABLE 279 SILGAN HOLDINGS INC.: COMPANY OVERVIEW
             11.12.14 VETTER PHARMA INTERNATIONAL GMBH
                          TABLE 280 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 318)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current market size for pharmaceutical packaging. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, the market breakdown and data triangulation methodologies were used to estimate the market size of segments and sub-segments.

Secondary Research

In the secondary research process, various secondary sources such as Factiva, Bloomberg, World Bank, Statista, Packaging Industry Associations, Trademap, Zauba, were referred to for identifying and collecting information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, regulations form agencies such as the Food & Drug Administration (FDA), World Health organization (WHO), The European Federation of Pharmaceutical Industries and Associations (EFPIA), Pharmaceuticals Export Promotion Council of India, regulatory bodies, and databases.

Primary Research

Extensive primary research has been conducted after acquiring an understanding of the pharmaceutical packaging market scenario through secondary research The pharmaceutical packaging market comprises several stakeholders such as raw material suppliers, distributors of pharmaceutical packaging, end-users, and regulatory organizations in the supply chain. The demand side of this market consists of pharmaceutical drug manufacturers, medical drug filling contractors, hospitals, labs, research institutes, and other healthcare institutions. Several primary interviews have been conducted with market experts from both the demand- (pharmaceutical packaging manufacturers) and supply-side (end-product manufacturers, buyers, and distributors) players across six major regions, namely, North America, Western Europe, Eastern & Central Europe, Asia Pacific, Middle East & Africa, and South America.

Following is the breakdown of primary respondents

Pharmaceutical Packaging Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the pharmaceutical packaging market. These methods were also used extensively to estimate the size of various sub-segments in the market. The research methodology used to estimate the market size includes the following:

  • The key players, raw material, types, and drug delivery modes in the industry and markets were identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value and volume, were determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size—using the market size estimation process explained above—the market was split into several segments and sub-segments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply of pharmaceutical packaging and their applications.

Report Objective:

  • To analyze and forecast size of the pharmaceutical packaging market in terms of value and volume.
  • To provide detailed information about the key factors (drivers, restraints, opportunities, and challenges) influencing the growth of the market
  • To analyze and forecast the market by type, by raw material, drug delivery, and region.
  • To forecast the size of the market with respect to five regions: Asia Pacific, Europe, North America, South America, and the Middle East & Africa, along with their key countries
  • To strategically analyze micro markets with respect to individual trends, future prospects, and their contribution to the overall market
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape for market leaders.
  • To analyze competitive developments such as mergers & acquisitions, new product developments, investments & expansions, and agreements & partnerships in the market
  • Strategically profile key players and comprehensively analyze their market shares and core competencies.

Available Customizations:

MarketsandMarkets offers customizations according to the specific needs of the companies with the given market data.

The following customization options are available for the pharmaceutical packaging market report:

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company

Regional Analysis

  • A further breakdown of the pharmaceutical packaging market, by segments

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
Report Code
CH 3482
Published ON
Nov, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Packaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback